ID: ALA4779035

Max Phase: Preclinical

Molecular Formula: C38H60N8O8

Molecular Weight: 756.95

Molecule Type: Unknown

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@@H]1Cc2ccc(cc2)OCCCCCC(=O)N[C@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)O

Standard InChI:  InChI=1S/C38H60N8O8/c1-5-24(4)32(35(50)44-29(37(52)53)21-23(2)3)45-33(48)28-22-25-14-16-26(17-15-25)54-20-8-6-7-13-31(47)42-27(11-9-18-41-38(39)40)36(51)46-19-10-12-30(46)34(49)43-28/h14-17,23-24,27-30,32H,5-13,18-22H2,1-4H3,(H,42,47)(H,43,49)(H,44,50)(H,45,48)(H,52,53)(H4,39,40,41)/t24-,27+,28-,29-,30-,32-/m0/s1

Standard InChI Key:  LTVAGLBMDPWQGE-MPNCUWFXSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 756.95

Molecular Weight (Monoisotopic): 756.4534

AlogP: 1.55

#Rotatable Bonds: 13

Polar Surface Area: 245.14

Molecular Species: ZWITTERION

HBA: 8

HBD: 8

#RO5 Violations: 2

HBA (Lipinski): 16

HBD (Lipinski): 9

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 4.11

CX Basic pKa: 11.63

CX LogP: 0.01

CX LogD: 0.01

Aromatic Rings: 1

Heavy Atoms: 54

QED Weighted: 0.08

Np Likeness Score: 0.64

References

1. Chartier M,Desgagné M,Sousbie M,Côté J,Longpré JM,Marsault E,Sarret P.  (2021)  Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.,  64  (4.0): [PMID:33538583] [10.1021/acs.jmedchem.0c01726]

Source

Source(1):

• Scientific Literature